Allscripts Affirms Q4 Guidance

Allscripts Healthcare Solutions, a healthcare information technology company, affirmed Q4 guidance provided in November.

The company said in November it expected revenue between $420 million and $435 million,straddling the $421.2 million average estimate from analysts polled by Capital IQ, and adjusted earnings per share between $0.14 and $0.16, straddling the Street estimate of $0.15.

The company initiated 2017 revenue guidance between $1.71 to $1.74 billion, topping the consensus of $1.69 billion. The company said it expects adjusted EPS growth of 10% to 15% for the year.

Leave a Comment